FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Allergy topics
Autoimmune
Prophylactic
Ophthalmic
Autoimmune Disorder
Immune Disorder
Dermatitis
Staurosporin
Aspergillosis
Angioedema
Allergic Rhinitis
Food Allergy
Therapeutical
Bronchopulmonary
Staurosporine
Sudden Infant Death

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Allergy patents



      
           
This page is updated frequently with new Allergy-related patent applications. Subscribe to the Allergy RSS feed to automatically get the update: related Allergy RSS feeds. RSS updates for this page: Allergy RSS RSS


Date/App# patent app List of recent Allergy-related patents
10/23/14
20140316772
 Verification of extracted data patent thumbnailVerification of extracted data
Facts are extracted from speech and recorded in a document using codings. Each coding represents an extracted fact and includes a code and a datum.
10/23/14
20140315888
 Novel heterocyclic derivatives and their uses patent thumbnailNovel heterocyclic derivatives and their uses
The present invention relates to novel heterocyclic compounds useful in preparing drugs for treatment of diseases associated with various functions of the histamine 4 receptor. Especially, the said drugs are useful for treatment of inflammatory diseases, allergy, pain, nasal polyps, rhinitis, chronic sinusitis, nasal congestion, nasal itch, asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, atopic dermatitis, psoriasis, eczema, pruritus, itchy skin, urticaria, idiopathic chronic urticaria, scleroderma, conjunctivitis, keratoconjunctivitis, ocular inflammation, dry eye, cardiac dysfunction, arrhythmia, atherosclerosis, multiple sclerosis, inflammatory bowel disease (including colitis, crohn's disease, ulcerative colitis), inflammatory pain, neuropathic pain, osteoarthritic pain, autoimmune thyroid disease, immune-mediated (also known as type i) diabetes, lupus, post-operative adhesions, vestibular disorders and cancer..
10/23/14
20140314800
 Beta-lactoglobulin peptides for treating cow's milk protein allergy patent thumbnailBeta-lactoglobulin peptides for treating cow's milk protein allergy
The present invention relates to a nutritional, preferably enteral, composition for use in the treatment of cow's milk allergy in infants allergic to cow's milk containing specific beta-lactoglobulin peptides, which are able to reduce, in particular abolish the acute symptoms of cow's milk protein allergy.. .
10/09/14
20140303089
 Plant hsp70 for use in the treatment of food allergy patent thumbnailPlant hsp70 for use in the treatment of food allergy
Object of the invention is to provide a treatment for food allergy, in particular for peanut or milk allergy. This object was met by providing a plant hsp70 or a hydrolysate thereof for use in the prophylactic or therapeutic treatment of a food allergy..
10/09/14
20140302153
 Methods and treatment for allergies and inflammation associated with gastrointestinal diseases patent thumbnailMethods and treatment for allergies and inflammation associated with gastrointestinal diseases
Methods of the prophylaxis of the development of allergy in a patient at risk of sensitization to an antigen(s) or allergen(s) due to impaired gastrointestinal functions include administering a mast cell inhibitor, e.g., ketotifen, e.g., ketotifen fumarate. Methods for prophylactically treating, reducing, delaying or controlling gastrointestinal disorders include administering a mast cell stabilizer, e.g., ketotifen to a patient in need thereof.
10/09/14
20140302071
 Peptides for vaccine patent thumbnailPeptides for vaccine
The present invention relates to compositions comprising peptides for preventing or treating allergy to house dust mites, and in particular to optimal combinations of peptides for preventing or treating said allergy.. .
10/09/14
20140302045
 Igy composition for use in celiac disease patent thumbnailIgy composition for use in celiac disease
The present invention relates to an igy composition characterized in that said igy composition contains igy antibodies, fragments, and/or fab fragments thereof that specifically bind to a peptide with the amino acid sequence of seq id no: 1 and to the use of this igy composition in the therapy of celiac disease, rheumatism, and/or wheat allergy.. .
10/02/14
20140296482
 Method to screen for selective peptides that  inhibit the biological activity of calcineurin patent thumbnailMethod to screen for selective peptides that inhibit the biological activity of calcineurin
The invention relates to the biotechnology sector involving the area of human health. More specifically, the invention is based on the surprising usefulness of peptides lxvpc1, c3 and c4 as efficient selective inhibitors of the calcineurin signalling pathway (cn)-nfat and the phosphate activity of cn.
10/02/14
20140296224
 Quinoline derivatives as pi3 kinase inhibitors patent thumbnailQuinoline derivatives as pi3 kinase inhibitors
Invented is a method of inhibiting the activity/function of pi3 kinases using quinoline derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinoline derivatives..
09/18/14
20140276196
 System and method for allergy testing patent thumbnailSystem and method for allergy testing
An allergy testing device is formed by a blister pack containing a series of collapsible chambers each associated with an allergen and a lancet. The allergy testing device may be placed adjacent to a patient's skin and actuated by applying pressure to the collapsible chambers to open the chambers and release the reagents contained therein.
09/18/14
20140274943
Medicinal cream made using silver sulphadiazine and chitosan and a process to make it
The present invention is directed to a composition for treating bacterial skin infections, along with skin rejuvenation. More particularly, the present invention relates to a pharmaceutical cream comprising a biopolymer, and an antibacterial active ingredient.
09/18/14
20140267088
Touch panel pen thereof
A touch panel pen comprising: a pen is a conductive rod with a connector in front; a fixed stand is a conductive body located in connector of the pen, a through-hole is on the center of the fixed stand and a flange is on the center periphery to separate the fixed stand into front and rear; a conductive textile is convex installed inside the through-hole of the fixed stand, the conductive layer of the conductive textile is formed by vacuum sputtering (physics electroplating) or with no electrolytic plating (chemical plating); a plug is installed inside the through-hole of the fixed stand to stop the conductive textile. By this design, the conductive textile convex installed on the fixed stand formed by vacuum sputtering plating can be thinner in structure, faster in induction; elasticity offers higher accuracy, effectively for more convenience with no wastewater pollution, no environmental problem and no allergy reaction and has antibacterial effect..
09/11/14
20140256942
Benzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor
Benzoimidazol-2-yl pyrimidines, purification methods for the same, and pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by h4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritus.. .
09/11/14
20140255434
Phl p 5a derivatives having reduced allergeneity and retained t-cell reactivity
The present invention relates to the preparation and use of variants of the group 5 allergen of the pooideae which are characterised by reduced ige reactivity compared with the known wild-type allergens and at the same time by substantially retained reactivity with t lymphocytes. These hypoallergenic allergen variants can be employed for the specific immunotherapy (hyposensitisation) of patients having grass pollen allergy or for the preventative immunotherapy of grass pollen allergies..
09/04/14
20140249048
Novel prostate kallikrein allergen
Methods for in vitro diagnosis of type i allergy comprises the steps of contacting an immunoglobulin-containing body fluid sample from a patient suspected of having type i allergy with a variant or fragment of the mature protein, amino acids 25-260, of the polypeptide of seq id no: 1, which variant or fragment shares epitopes for antibodies with the mature protein, amino acids 25-260, of the polypeptide of seq id no: 1; and detecting the presence, in the sample, of ige antibodies specifically binding to the variant or fragment. The presence of such ige antibodies specifically binding to the variant or fragment is indicative of a type i allergy in the patient..
08/28/14
20140243867
Surgically invasive pointed articles for skin penetration and methods for their preparation
A surgically invasive pointed article for skin penetration and its fabrication method are presented. The present invention comprises a protruding sharp end portion and a body portion, the protruding sharp end portion comprising at least one penetration tip that can be disabled after use.
08/28/14
20140242094
Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cells
The present invention provides compositions and methods useful for promoting or reducing t-cell trafficking to a target tissue. Also provided are compositions and methods useful for promoting or inhibiting antigen-presenting cell (apc) activation.
08/28/14
20140241995
Micropatch for assessing chemical contact allergy
The micropatch of the present invention provides a reliable and effective system of elicitation necessary for the diagnostic identification of allergy cases whilst substantially reducing the chances of sensitising subjects, the present invention employs a micropatch.. .
08/21/14
20140234521
Low fat mayonnaise composition and method of producing the same
Provided are a low fat mayonnaise composition to which cellulose ether is applied, and a method of producing the same, in which the low fat mayonnaise composition includes 50 wt % or less of an emulsion with respect to the total weight of the composition, and cellulose ether and an excipient as a fat substitute. Therefore, with the mayonnaise composition, low fat mayonnaise which includes an oil and fat content of ½ or less may be produced from only a vegetable material having phase stability at various temperatures without using eggs which may lead to an allergy and may serve as a primary source of increasing cholesterol..
08/21/14
20140234423
Programming of cells for tolerogenic therapies
Biomaterial systems, e.g., gel scaffolds, are used in vivo to recruit immune cells and promote their activation towards a non-inflammatory phenotype, thereby leading suppression of inflammation. The compositions and methods are useful to reduce the severity of autoimmunity, chronic inflammation, allergy, and periodontal disease..
08/21/14
20140234408
Beverage compositions and other formulations for treating allergies and methods for making the same
A composition for preventing and/or alleviating an allergy related condition and methods of making such compositions are disclosed herein. A composition in accordance with a particular embodiment can include honey having pollen derived from a known plant species and/or from a known geographic location.
08/14/14
20140228304
Combined allergy treatment and anti-drying compositions and related methods
Compositions and methods for alleviating an allergy condition while also reducing a drying effect of an allergy treatment composition or another anti-mucosal composition. In some embodiments and implementations, a composition may be provided comprising an allergy treatment composition comprising an antihistamine in a therapeutically effective amount for treating the allergy condition in the human having the allergy condition.
08/07/14
20140220012
Novel vista-ig constructs and the use of vista-ig for treatment of autoimmune, allergic and inflammatory disorders
The present invention relates to a fusion proteins comprising regulatory t cell protein, vista (v-domain immunoglobulin suppressor of t cell activation (pd-l3) and an immunoglobulin protein (ig), preferably also containing a flexible linker intervening the vista and ig fc polypeptide. The invention also provides the use of vista polypeptides, multimeric vista polypeptides, vista-conjugates (e.g., vista-ig), and vista antagonists for the treatment of autoimmune disease, allergy, and inflammatory conditions, especially lupus, multiple sclerosis, psoriasis, psoriatic arthritis, multiple sclerosis, crohn's disease, inflammatory bowel disease and type 1 or type 2 diabetes..
08/07/14
20140219921
Immunomodulating compositions and methods
The disclosure provides compositions in the form of cells exhibiting the phenotype of a mesenchymal stem cell and uses of such cells in the preparation of medicament and the treatment of an allergic reaction in an asthmatic subject. Also provided are methods of inducing tolerance to an allergen in an asthmatic subject and methods of assessing a non-asthmatic subject for amenability to allergy treatment by administering mesenchymal stem cells..
07/31/14
20140213842
Methods and devices for treating primary headache
Non-invasive electrical nerve stimulation devices and magnetic stimulation devices are disclosed, along with methods of treating medical disorders using energy that is delivered noninvasively by such devices. The disorders comprise migraine and other primary headaches such as cluster headaches, including sinus symptoms that resemble an immune-mediated response (“sinus” headaches), irrespective of whether those symptoms arise from an allergy that is co-morbid with the headache.
07/31/14
20140213644
Formulations and methods for prevention and treatment of oral allergy syndrome
A method and formulation for the prevention and treatment for oral allergy syndrome (oas), also referred to as pollen-associated food allergy syndrome (pfas), is disclosed. The formulation significantly reduces or prevents symptoms related to oral allergy syndrome while having a superb safety record.
07/31/14
20140212492
Oral enzyme compositions for intestinal delivery
The present disclosure describes compositions for intestinal delivery of enzyme formulations and methods of treating health problems with these formulations. More specifically, the enzyme formulations include at least one histaminase and various methods of treatment of physical conditions, such as inflammation, allergy, histamine intolerance, and intestinal cancer..
07/10/14
20140194586
Method for treatment of synthetic rubber products, a system for treatment, the resulting rubber products, and use of a method to reduce type iv allergenicity of rubber products
The present invention relates to a method of reducing type iv rubber allergy of synthetic rubber latex products caused by chemical residues remaining after manufacture of the synthetic rubber products by reducing levels of chemical residues found for said products, said method comprising the steps of: subjecting said products to a wash in a strong alkaline solution to remove the chemical residues remaining after manufacture of the rubber latex products, and a system for reducing type iv allergenicity of synthetic rubber products caused by chemical residues remaining after manufacture of the synthetic rubber latex products by reducing residual levels of chemical residues found for said products, and a product, such as a glove, manufactured from synthetic rubber latex processed in accordance with the method and/or using the system. Further the invention relates to a use of a method of subjecting products to said wash and raising the temperature to at least 100c to remove the chemical residues remaining after manufacture of the synthetic rubber products..
07/10/14
20140193534
Epicatechin for alleviating symptoms of allergy
The present invention relates to epicatechin for use in the prevention or reduction of symptoms of an allergic disorder and/or an allergic reaction. The invention further relates to epicatechin for said use in the form of food, food product, food supplement or pharmaceutical products..
07/10/14
20140193450
Peptide carrier fusion proteins as allergy vaccines
The present invention relates to a polypeptide comprising at least three peptide fragments consisting of 10 to 50 consecutive amino acid residues of at least one wild-type allergen fused to the n- and c-terminus of a surface polypeptide of a virus of the hepadnaviridae family or at least one fragment of said surface polypeptide.. .
07/10/14
20140193396
Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
The invention provides immune regulatory oligonucleotides (iro) as antagonist of tlrs and methods of use thereof. These iros have unique sequences that inhibit tlr-mediated signaling in response to a tlr ligand or tlr agonist.
07/03/14
20140187892
Device with integrated allergy testing
The disclosure provides an allergy detection system for use during catheterization. The allergy detection system is incorporated into specialized syringes, connectors for use with standard syringes, or can be an independent test module designed for the sole purpose of allergy detection.
07/03/14
20140186403
Peptide for vaccine
The present invention relates to compositions comprising peptides for preventing or treating allergy to house dust mites, and in particular to optimal combinations of peptides for preventing or treating said allergy.. .
05/29/14
20140149114
Automatic decision support
Speech is transcribed to produce a transcript. At least some of the text in the transcript is encoded as data.
05/29/14
20140144555
Bio-co-cr-mo alloy with ion elution suppressed by structure control, and process for producing same
This invention provides a technique for rendering bio-toxicity such as allergy toxicity derived from ni trace impurity, i.e., nickel toxicity, which is unavoidably present in a bio-co—cr—mo alloy or an ni-free stainless steel alloy unharmful, characterized in that an element selected from the group consisting of the group 4, 5 and 13 elements of the periodic table, particularly an element selected from the group consisting of the group 4 elements of the periodic table, is added to the alloy composition. The additive element is preferably an element selected from the group consisting of zirconium and titanium, more preferably zirconium..
05/22/14
20140142321
Benzimidazole derivatives as pi3 kinase inhibitors
This invention relates to the use of benzimidazole derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3′ oh kinase family (hereinafter pi3 kinases), suitably, pi3kα, pi3kδ, pi3kβ, and/or pi3kγ. Suitably, the present invention relates to the use of benzimidazoles in the treatment of one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries.
05/22/14
20140141077
Composition for use in treating and preventing inflammation related disorder
The present invention is related to a use for treating and preventing inflammation related disorder of a composition containing a drug and hyaluronic acid (ha) or ha mixture, whereas the ha or the ha mixture as a delivery vehicle can be a formulation including at least two has having different average molecular weights. The composition has been demonstrated to be capable of reducing the therapeutic dose of a drug on the treatment and prevention of inflammation related disorders is acute inflammatory disease, chronic obstructed pulmonary disease, coeliac disease, conjunctivitis, otitis, allergic rhinitis, gingivitis, aphthous ulcer, bronchitis, gastroesophageal reflux disease (gerd), esophagitis, gastritis, enteritis, peptic ulcer, inflammatory bowel disease (ibd), crohn's disease, irritable bowel syndrome (ibs), intestinal inflammation or allergy, urethritis, cystitis, vaginitis, proctitis, eosinophilic gastroenteritis, or rheumatoid arthritis..
05/15/14
20140135361
Anti-allergy benzocycloheptathiophene derivatives
A method for treating an allergic reaction, or allergy diseases or disorders includes administering a therapeutically effective composition comprising a compound of formula i or a pharmaceutically acceptable salt, solvate or prodrug thereof and a pharmaceutically acceptable carrier, vehicle or excipient to a subject in need thereof.. .
05/15/14
20140135290
Macrocyclic prodrug compounds useful as therapeutics
The present invention includes macrocyclic prodrug compounds, pharmaceutical compositions containing them. The present invention also includes use of these compounds in the treatment of various diseases including an autoimmune disease, an inflammatory disease, a neurological or neurodegenerative disease, cancer, a cardiovascular disease, allergy, asthma, a hormone-related disease, and tumors or symptoms resulting from neurofibromatosis..
05/15/14
20140134739
Method of genetically altering and producing allergy free cats
A transgenic cat with a phenotype characterized by the substantial absence of the major cat allergen, fel d i. The phenotype is conferred in the transgenic cat by disrupting the coding sequence of the target gene with a specialized construct.
05/08/14
20140127289
Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
In various embodiments, the present invention provides pharmaceutical compositions comprising fatty acids and methods for treating subjects using same.. .
05/08/14
20140124106
Silver-white copper alloy and method of producing silver-white copper alloy
Provided are a silver-white copper alloy which has superior mechanical properties such as hot workability, cold workability, or press property, color fastness, bactericidal and antibacterial properties, and ni allergy resistance; and a method of producing such a silver-white copper alloy. The silver-white copper alloy includes 51.0 mass % to 58.0 mass % of cu; 9.0 mass % to 12.5 mass % of ni; 0.0003 mass % to 0.010 mass % of c; 0.0005 mass % to 0.030 mass % of pb; and the balance of zn and inevitable impurities, in which a relationship of 65.5≦[cu]+1.2×[ni]≦70.0 is satisfied between a content of cu [cu] (mass %) and a content of ni [ni] (mass %).
05/01/14
20140121645
Methods and apparatus for the cvcs
The present invention provides an indirect method and accompanying apparatus for supplying a high concentration of medicaments, particularly antibiotics, to the nasal sinuses by first loading the medicament into the cerebrospinal venous system (cvcs) via a valsalva maneuver. Because the cvcs is a valveless, three-dimensional closed system, traditional physiological dogma such as veins always draining tissues does not always apply.
05/01/14
20140121356
Hypoallergenic mutant polypeptides based on fish parvalbumin
The present invention relates to non-naturally occurring polypeptides derived from fish allergens such as parvalbumin cyp c 1.01 from carp. The polypeptides display reduced allergenic activity and are useful as allergy vaccines for treatment of sensitized allergic patients and for prophylactic vaccination..
05/01/14
20140120563
Allergen testing platform for use with mobile electronic devices
An allergy testing system for use with a mobile electronic device having a camera includes a housing that can be attached to the mobile electronic device. First and second light sources within the housing are configured to illuminate, respectively, a test sample and a control sample.
05/01/14
20140120123
Fusion proteins for the treatment of allergic diseases
The present invention relates to a fusion protein comprising a first peptide and a second peptide linked together with a linker, wherein the first peptide is an allergen and the second peptide is a targeting unit and the second targeting unit peptide is a fgl-2 c-terminal peptide according to seq id no 1. Provided herein are also uses of said fusion protein as a vaccine for treating shrimp allergy, as well as a vaccine composition and methods of its production..
04/24/14
20140113964
Method of preventing and treating allergic airway diseases via intranasal gabexate mesilate
The present invention discloses a method of preventing and treating allergic airway diseases via intranasal gabexate mesilate, comprising administrating a pharmaceutically effective amount of a composition comprising a gabexate mesilate via nasal spray to prevent and treat allergy induced by a serine protease type allergen.. .
04/24/14
20140113915
Novel pyridopyrimidine derivatives and use thereof
The invention provides novel substituted pyridopyrimidines represented by formula i or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as inhibitors of the phosphoinositide 3′ oh kinase family (pi3k) for the treatment of inflammatory diseases, cancer, cardiovascular diseases, allergy, asthma and autoimmune disorders..
04/24/14
20140112822
Silver-white copper alloy and method of producing silver-white copper alloy
Provided are a silver-white copper alloy which has superior mechanical properties such as hot workability, cold workability, or press property, color fastness, bactericidal and antibacterial properties, and ni allergy resistance; and a method of producing such a silver-white copper alloy. The silver-white copper alloy includes 51.0 mass % to 58.0 mass % of cu; 9.0 mass % to 12.5 mass % of ni; 0.0003 mass % to 0.010 mass % of c; 0.0005 mass % to 0.030 mass % of pb; and the balance of zn and inevitable impurities, in which a relationship of 65.5≦[cu]+1.2×[ni]≦70.0 is satisfied between a content of cu [cu] (mass %) and a content of ni [ni] (mass %).
04/17/14
20140107398
Methods and devices for treating primary headache
Non-invasive electrical nerve stimulation devices and magnetic stimulation devices are disclosed, along with methods of treating medical disorders using energy that is delivered noninvasively by such devices. The disorders comprise migraine and other primary headaches such as cluster headaches, including sinus symptoms that resemble an immune-mediated response (“sinus” headaches), irrespective of whether those symptoms arise from an allergy that is co-morbid with the headache.
04/17/14
20140107397
Methods and devices for treating primary headache
Non-invasive electrical nerve stimulation devices and magnetic stimulation devices are disclosed, along with methods of treating medical disorders using energy that is delivered noninvasively by such devices. The disorders comprise migraine and other primary headaches such as cluster headaches, including sinus symptoms that resemble an immune-mediated response (“sinus” headaches), irrespective of whether those symptoms arise from an allergy that is co-morbid with the headache.
04/17/14
20140107102
Ocular allergy treatments
Compositions, kits and methods for the treatment or prevention of ocular allergies and inflammation and the symptoms thereof comprising alcaftadine or a pharmaceutically acceptable salt thereof.. .
04/10/14
20140100234
Quinoline derivatives as pi3 kinase inhibitors
Invented is a method of inhibiting the activity/function of pi3 kinases using quinoline derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinoline derivatives..
04/10/14
20140099331
Zwitterionic immunomodulators for the teatment of asthma and allergy
Methods and products for treating and protecting against asthma and allergic conditions are provided. The methods and products are related to certain naturally occurring and synthetic zwitterionic polymers which are found to induce certain t regulatory (treg) cells and to exert immunosuppressive effects in vitro and in vivo..
04/03/14
20140093541
Treatment for peanut allergy
The present invention relates to oral immunotherapy for the desensitisation of patients who are hypersensitive to peanut allergen. The immunotherapy comprises increasing the oral dose daily dose of peanut protein administered to the patient at intervals of at least 2 weeks in a series of increments from an initial dose to a maximum dose, the series of dose increments including 2 mg, 5 mg, 12.5 mg, 25 mg, 50 mg, 100 mg, 200 mg, 400 mg and 800 mg; administering a daily oral dose of the maximum dose of peanut protein for at least 2 years and then administering a weekly oral dose of the maximum dose of peanut protein for at least 2 years..
04/03/14
20140093509
Screening method for the identification of agents capable of activating cd4+cd25+ regulatory t-cells through interactions with the hiv-1 gp120 binding site on cd4
The present invention relates specific activation of a regulatory t cell via a specific cd4 epitope and uses thereof, e.g. For the treatment of an autoimmune disease or an allergy or asthma or graft rejection or tolerance induction..
03/27/14
20140088172
Rnai-mediated inhibition of histamine receptor h1-related conditions
Rna interference is provided for inhibition of histamine receptor h1 mrna expression, in particular, for treating patients having an hrh1-related condition or at risk of developing an hrh1-related condition such as allergic conjunctivitis, ocular inflammation, dermatitis, rhinitis, asthma, or allergy.. .
03/20/14
20140081071
Methods and devices for treating primary headache
Non-invasive electrical nerve stimulation devices and magnetic stimulation devices are disclosed, along with methods of treating medical disorders using energy that is delivered noninvasively by such devices. The disorders comprise migraine and other primary headaches such as cluster headaches, including sinus symptoms that resemble an immune-mediated response (“sinus” headaches), irrespective of whether those symptoms arise from an allergy that is co-morbid with the headache.
03/20/14
20140080730
Method for predicting severity of allergic reaction
The present invention provides methods for determining a likelihood of a degree of allergic reaction or a severity thereof using a threshold value rather than the binding activity number between the immunoglobulin of the subject and a test composition comprising a marker protein moiety of the allergy inducing material. In one particular embodiment of the invention, methods are provided for determining a likelihood of a degree of allergic reaction severity of a subject to peanuts using a threshold value of binding between immunoglobulin e (ige) of the subject and ara h 2 moiety and ara h 6 moiety..
02/27/14
20140056933
Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
The application is related to compositions and methods for the treatment of hypersensitivity, wherein the compositions comprise a particle packaged with immunostimulatory nucleic acids. The compositions of the invention are particularly useful in the treatment of atopic eczema, asthma and ige-mediated allergy (type i allergy), especially pollen allergy and house dust allergy..
02/27/14
20140056892
Vista-ig for treatment of autoimmune, allergic and inflammatory disorders
The present invention relates to a fusion proteins comprising regulatory t cell protein, vista (v-domain immunoglobulin suppressor of t cell activation (pd-l3) and an immunoglobulin protein (ig). The invention also provides the use of vista polypeptides, multimeric vista polypeptides, vista-conjugates (e.g., vista-ig), and vista antagonists for the treatment of autoimmune disease, allergy, and inflammatory conditions..
02/20/14
20140051677
Novel compound useful for the treatment of degenerative and inflammatory diseases
Novel pyrrazolopyridines according to formula i, able to inhibit jak are disclosed, these compounds may be prepared as a pharmaceutical composition, and may be used for the prophylaxis and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, allergy, inflammatory conditions, autoimmune diseases, proliferative diseases, transplant rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of il6 or interferons.. .
02/20/14
20140050750
Vaccine peptide combinations against cat allergy
The present invention relates to compositions comprising peptides for preventing or treating allergy to cats, and in particular to optimal combinations of peptides. .


Popular terms: [SEARCH]

Allergy topics: Autoimmune, Prophylactic, Ophthalmic, Autoimmune Disorder, Immune Disorder, Dermatitis, Staurosporin, Aspergillosis, Angioedema, Allergic Rhinitis, Food Allergy, Therapeutical, Bronchopulmonary, Staurosporine, Sudden Infant Death

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Allergy for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Allergy with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.3548

3113

1 - 1 - 71